Examination of the relationship between D-amino acid profiles and cognitive function in individuals with mild cognitive impairment: a machine learning approach.

Journal: The international journal of neuropsychopharmacology
PMID:

Abstract

BACKGROUND: The global prevalence of dementia is significantly increasing. Early detection and prevention strategies, particularly for mild cognitive impairment (MCI), are crucial but currently hindered by the lack of established biomarkers. Here, we aimed to develop a high-precision screening method for MCI by combining D-amino acid profiles from peripheral blood samples with noninvasive subject information using nonlinear machine learning (ML) algorithms.

Authors

  • Sou Sugiki
    Human Health Care Products Research, Kao Corporation, Tokyo, Japan.
  • Shigeki Tsuchiya
    Analytical Science Research, Kao Corporation, Tokyo, Japan.
  • Ren Kimura
    Analytical Science Research, Kao Corporation, Tokyo, Japan.
  • Shun Katada
    Human Health Care Products Research, Kao Corporation, Tokyo, Japan.
  • Koichi Misawa
    Human Health Care Products Research, Kao Corporation, Tokyo, Japan.
  • Hisashi Tsujimura
    Analytical Science Research, Kao Corporation, Tokyo, Japan.
  • Masanobu Hibi
    Human Health Care Products Research, Kao Corporation, Tokyo, Japan.